APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Selected research

Market Outlook & Growth Opportunities

Global Codeine Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchCodeine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

This report provides an overview of the global Codeine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Codeine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Codeine market size, projected growth trends, production technologies, key applications, and end-use industries.

Codeine Segment by Company

Taiji

Mallinckrodt

TEVA

Johnson & Johnson

Medreich

Sanofi Aventis

Cipla

Hikma

Pharmaceutical Associates

Novartis

Apotex

Mylan

Aristo Pharma GmbH

Lannett Company

Laboratoire Riva

Codeine Segment by Ingredient

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Codeine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Codeine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Codeine significant trends, drivers, influence factors in global and regions.

6. To analyze Codeine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine industry.

Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Codeine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Codeine Industry Trends Table 2. Codeine Industry Drivers Table 3. Codeine Industry Opportunities and Challenges Table 4. Codeine Industry Restraints Table 5. Global Codeine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Codeine Revenue Share by Company (2021-2026) Table 7. Global Codeine Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Codeine Sales Volume Share by Company (2021-2026) Table 9. Global Codeine Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Codeine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Codeine Key Company Manufacturing Base & Headquarters Table 12. Global Codeine Company, Product Type & Application Table 13. Global Codeine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single-ingredient Codeine Table 18. Significant Companies of Multi-ingredient Medications Table 19. Global Codeine Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Codeine Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Codeine Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Codeine Sales Volume Share by Type (2021-2026) Table 23. Global Codeine Sales Volume Share by Type (2027-2032) Table 24. Global Codeine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Codeine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Codeine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Codeine Sales Value Share by Type (2021-2026) Table 28. Global Codeine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Narcotic Analgesic Table 30. Significant Companies of Antitussive Table 31. Significant Companies of Others Table 32. Global Codeine Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Codeine Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Codeine Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Codeine Sales Volume Share by Application (2021-2026) Table 36. Global Codeine Sales Volume Share by Application (2027-2032) Table 37. Global Codeine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Codeine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Codeine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Codeine Sales Value Share by Application (2021-2026) Table 41. Global Codeine Sales Value Share by Application (2027-2032) Table 42. Global Codeine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Codeine Sales by Region (2021-2026) & (M Units) Table 44. Global Codeine Sales Market Share by Region (2021-2026) Table 45. Global Codeine Sales by Region (2027-2032) & (M Units) Table 46. Global Codeine Sales Market Share by Region (2027-2032) Table 47. Global Codeine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Codeine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Codeine Sales Value Share by Region (2021-2026) Table 50. Global Codeine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Codeine Sales Value Share by Region (2027-2032) Table 52. Global Codeine Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Codeine Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Codeine Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Codeine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Codeine Sales by Country (2021-2026) & (M Units) Table 57. Global Codeine Sales Market Share by Country (2021-2026) Table 58. Global Codeine Sales by Country (2027-2032) & (M Units) Table 59. Global Codeine Sales Market Share by Country (2027-2032) Table 60. Global Codeine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Codeine Sales Value Market Share by Country (2021-2026) Table 62. Global Codeine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Codeine Sales Value Market Share by Country (2027-2032) Table 64. Taiji Company Information Table 65. Taiji Business Overview Table 66. Taiji Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Taiji Codeine Product Portfolio Table 68. Taiji Recent Development Table 69. Mallinckrodt Company Information Table 70. Mallinckrodt Business Overview Table 71. Mallinckrodt Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Mallinckrodt Codeine Product Portfolio Table 73. Mallinckrodt Recent Development Table 74. TEVA Company Information Table 75. TEVA Business Overview Table 76. TEVA Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. TEVA Codeine Product Portfolio Table 78. TEVA Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Codeine Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Medreich Company Information Table 85. Medreich Business Overview Table 86. Medreich Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Medreich Codeine Product Portfolio Table 88. Medreich Recent Development Table 89. Sanofi Aventis Company Information Table 90. Sanofi Aventis Business Overview Table 91. Sanofi Aventis Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Sanofi Aventis Codeine Product Portfolio Table 93. Sanofi Aventis Recent Development Table 94. Cipla Company Information Table 95. Cipla Business Overview Table 96. Cipla Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Cipla Codeine Product Portfolio Table 98. Cipla Recent Development Table 99. Hikma Company Information Table 100. Hikma Business Overview Table 101. Hikma Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Hikma Codeine Product Portfolio Table 103. Hikma Recent Development Table 104. Pharmaceutical Associates Company Information Table 105. Pharmaceutical Associates Business Overview Table 106. Pharmaceutical Associates Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Pharmaceutical Associates Codeine Product Portfolio Table 108. Pharmaceutical Associates Recent Development Table 109. Novartis Company Information Table 110. Novartis Business Overview Table 111. Novartis Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Novartis Codeine Product Portfolio Table 113. Novartis Recent Development Table 114. Apotex Company Information Table 115. Apotex Business Overview Table 116. Apotex Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Apotex Codeine Product Portfolio Table 118. Apotex Recent Development Table 119. Mylan Company Information Table 120. Mylan Business Overview Table 121. Mylan Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Mylan Codeine Product Portfolio Table 123. Mylan Recent Development Table 124. Aristo Pharma GmbH Company Information Table 125. Aristo Pharma GmbH Business Overview Table 126. Aristo Pharma GmbH Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Aristo Pharma GmbH Codeine Product Portfolio Table 128. Aristo Pharma GmbH Recent Development Table 129. Lannett Company Company Information Table 130. Lannett Company Business Overview Table 131. Lannett Company Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. Lannett Company Codeine Product Portfolio Table 133. Lannett Company Recent Development Table 134. Laboratoire Riva Company Information Table 135. Laboratoire Riva Business Overview Table 136. Laboratoire Riva Codeine Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 137. Laboratoire Riva Codeine Product Portfolio Table 138. Laboratoire Riva Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Codeine Distributors List Table 142. Codeine Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Codeine Product Image Figure 2. Global Codeine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Codeine Sales (2021-2032) & (M Units) Figure 5. Global Codeine Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Codeine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single-ingredient Codeine Image Figure 10. Multi-ingredient Medications Image Figure 11. Global Codeine Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Codeine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Codeine Sales Volume Share by Type (2021-2032) Figure 14. Global Codeine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Codeine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Codeine Sales Value Share by Type (2021-2032) Figure 17. Narcotic Analgesic Image Figure 18. Antitussive Image Figure 19. Others Image Figure 20. Global Codeine Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Codeine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Codeine Sales Volume Share by Application (2021-2032) Figure 23. Global Codeine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Codeine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Codeine Sales Value Share by Application (2021-2032) Figure 26. Global Codeine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Codeine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Codeine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Codeine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Codeine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Codeine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Codeine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Codeine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Codeine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Codeine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Codeine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Codeine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Codeine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Codeine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Codeine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Codeine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Codeine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Codeine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Codeine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Taiji
  • Mallinckrodt
  • TEVA
  • Johnson & Johnson
  • Medreich
  • Sanofi Aventis
  • Cipla
  • Hikma
  • Pharmaceutical Associates
  • Novartis
  • Apotex
  • Mylan
  • Aristo Pharma GmbH
  • Lannett Company
  • Laboratoire Riva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Codeine Sales Value (2021-2032)
  4. 1.2.2 Global Codeine Sales Volume (2021-2032)
  5. 1.2.3 Global Codeine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Codeine Market Dynamics
  1. 2.1 Codeine Industry Trends
  2. 2.2 Codeine Industry Drivers
  3. 2.3 Codeine Industry Opportunities and Challenges
  4. 2.4 Codeine Industry Restraints
3 Codeine Market by Company
  1. 3.1 Global Codeine Company Revenue Ranking in 2025
  2. 3.2 Global Codeine Revenue by Company (2021-2026)
  3. 3.3 Global Codeine Sales Volume by Company (2021-2026)
  4. 3.4 Global Codeine Average Price by Company (2021-2026)
  5. 3.5 Global Codeine Company Ranking (2024-2026)
  6. 3.6 Global Codeine Company Manufacturing Base and Headquarters
  7. 3.7 Global Codeine Company Product Type and Application
  8. 3.8 Global Codeine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Codeine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Codeine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Codeine Market by Type
  1. 4.1 Codeine Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications
  4. 4.2 Global Codeine Sales Volume by Type
  5. 4.2.1 Global Codeine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Codeine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Codeine Sales Value by Type
  9. 4.3.1 Global Codeine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Codeine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Codeine Sales Value Share by Type (2021-2032)
5 Codeine Market by Application
  1. 5.1 Codeine Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Sales Volume by Application
  6. 5.2.1 Global Codeine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Codeine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Codeine Sales Value by Application
  10. 5.3.1 Global Codeine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Codeine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Codeine Sales Value Share by Application (2021-2032)
6 Codeine Regional Sales and Value Analysis
  1. 6.1 Global Codeine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Sales by Region (2021-2032)
  3. 6.2.1 Global Codeine Sales by Region: 2021-2026
  4. 6.2.2 Global Codeine Sales by Region (2027-2032)
  5. 6.3 Global Codeine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Codeine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Codeine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Codeine Sales Value by Region (2027-2032)
  9. 6.5 Global Codeine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Codeine Sales Value (2021-2032)
  12. 6.6.2 North America Codeine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Codeine Sales Value (2021-2032)
  15. 6.7.2 Europe Codeine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Codeine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Codeine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Codeine Sales Value (2021-2032)
  21. 6.9.2 South America Codeine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Codeine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Codeine Sales Value Share by Country, 2025 VS 2032
7 Codeine Country-level Sales and Value Analysis
  1. 7.1 Global Codeine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Codeine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Codeine Sales by Country (2021-2032)
  4. 7.3.1 Global Codeine Sales by Country (2021-2026)
  5. 7.3.2 Global Codeine Sales by Country (2027-2032)
  6. 7.4 Global Codeine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Codeine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Codeine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Codeine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Codeine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Codeine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Codeine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Codeine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Codeine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Codeine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Codeine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Codeine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Codeine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Codeine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Codeine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Codeine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Codeine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Codeine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Codeine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Codeine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Codeine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Codeine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Codeine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Codeine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Codeine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Codeine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Codeine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Codeine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Codeine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Codeine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Codeine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Codeine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Codeine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Codeine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Codeine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Codeine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Codeine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Codeine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Codeine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Codeine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Codeine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Codeine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Codeine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Codeine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Codeine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Codeine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Codeine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Codeine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Codeine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Codeine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Codeine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Codeine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Codeine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Codeine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Codeine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Codeine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Codeine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Codeine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Codeine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Codeine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Codeine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Codeine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Codeine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Codeine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Codeine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Codeine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Codeine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Codeine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Codeine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Codeine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Codeine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Codeine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Codeine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Codeine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Codeine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Codeine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Codeine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Codeine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Codeine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Codeine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Codeine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Codeine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Codeine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Codeine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Codeine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Codeine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Codeine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Taiji
  2. 8.1.1 Taiji Company Information
  3. 8.1.2 Taiji Business Overview
  4. 8.1.3 Taiji Codeine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Taiji Codeine Product Portfolio
  6. 8.1.5 Taiji Recent Developments
  7. 8.2 Mallinckrodt
  8. 8.2.1 Mallinckrodt Company Information
  9. 8.2.2 Mallinckrodt Business Overview
  10. 8.2.3 Mallinckrodt Codeine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mallinckrodt Codeine Product Portfolio
  12. 8.2.5 Mallinckrodt Recent Developments
  13. 8.3 TEVA
  14. 8.3.1 TEVA Company Information
  15. 8.3.2 TEVA Business Overview
  16. 8.3.3 TEVA Codeine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TEVA Codeine Product Portfolio
  18. 8.3.5 TEVA Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Codeine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Codeine Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Medreich
  26. 8.5.1 Medreich Company Information
  27. 8.5.2 Medreich Business Overview
  28. 8.5.3 Medreich Codeine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medreich Codeine Product Portfolio
  30. 8.5.5 Medreich Recent Developments
  31. 8.6 Sanofi Aventis
  32. 8.6.1 Sanofi Aventis Company Information
  33. 8.6.2 Sanofi Aventis Business Overview
  34. 8.6.3 Sanofi Aventis Codeine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Aventis Codeine Product Portfolio
  36. 8.6.5 Sanofi Aventis Recent Developments
  37. 8.7 Cipla
  38. 8.7.1 Cipla Company Information
  39. 8.7.2 Cipla Business Overview
  40. 8.7.3 Cipla Codeine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cipla Codeine Product Portfolio
  42. 8.7.5 Cipla Recent Developments
  43. 8.8 Hikma
  44. 8.8.1 Hikma Company Information
  45. 8.8.2 Hikma Business Overview
  46. 8.8.3 Hikma Codeine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Codeine Product Portfolio
  48. 8.8.5 Hikma Recent Developments
  49. 8.9 Pharmaceutical Associates
  50. 8.9.1 Pharmaceutical Associates Company Information
  51. 8.9.2 Pharmaceutical Associates Business Overview
  52. 8.9.3 Pharmaceutical Associates Codeine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pharmaceutical Associates Codeine Product Portfolio
  54. 8.9.5 Pharmaceutical Associates Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Codeine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Codeine Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Codeine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Codeine Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Mylan
  68. 8.12.1 Mylan Company Information
  69. 8.12.2 Mylan Business Overview
  70. 8.12.3 Mylan Codeine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mylan Codeine Product Portfolio
  72. 8.12.5 Mylan Recent Developments
  73. 8.13 Aristo Pharma GmbH
  74. 8.13.1 Aristo Pharma GmbH Company Information
  75. 8.13.2 Aristo Pharma GmbH Business Overview
  76. 8.13.3 Aristo Pharma GmbH Codeine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Aristo Pharma GmbH Codeine Product Portfolio
  78. 8.13.5 Aristo Pharma GmbH Recent Developments
  79. 8.14 Lannett Company
  80. 8.14.1 Lannett Company Company Information
  81. 8.14.2 Lannett Company Business Overview
  82. 8.14.3 Lannett Company Codeine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Lannett Company Codeine Product Portfolio
  84. 8.14.5 Lannett Company Recent Developments
  85. 8.15 Laboratoire Riva
  86. 8.15.1 Laboratoire Riva Company Information
  87. 8.15.2 Laboratoire Riva Business Overview
  88. 8.15.3 Laboratoire Riva Codeine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Laboratoire Riva Codeine Product Portfolio
  90. 8.15.5 Laboratoire Riva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Codeine Value Chain Analysis
  2. 9.1.1 Codeine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Codeine Sales Mode & Process
  6. 9.2 Codeine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Codeine Distributors
  9. 9.2.3 Codeine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst